Photo: Esteworld Opens Its First Representative Office in the UK in London ...

DALLAS, Aug. 11, 2025 (GLOBE NEWSWIRE) -- BHIANT, the workforce development arm of BioNTX, is charting new ground in biotechnology talent development and industry collaboration, strengthening North ...

The first patient in Cohort 3, the fifth patient in the trial, has completed the first week of cycle 1 following the successful safety review of Cohort 2 with no safety or tolerability issues observed ...

This facility is designed to provide expanded capacity and operational security as Kraig Labs scales up its recombinant spider silk manufacturing. The site will play a key role in supporting the ...

Basel, Switzerland – August 11, 2025 – FoRx Therapeutics, a clinical-stage biotechnology company developing precision anti-cancer therapeutics, today announced the dosing of the first patient in a ...

MediPharm Labs executive management team will also host a conference call and webcast on Thursday, August 14 th, 2025 at 10:00 a.m. (Eastern time) to discuss the Company’s financial results. North ...

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that Dr. Helen Thackray, chief research and developme ...

USPTO Issues Patent No. US 12,343,315 B2 covering topical cannabinoid compositions for clear skin. TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “C ...

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today reported ...

The notes will be general unsecured, senior obligations of Ligand and will accrue interest payable semiannually in arrears on April 1 and October 1 of each year, beginning on April 1, 2026. The notes ...

The leadership transition is part of the Board’s ongoing succession planning and aligns with the Company’s planned advancement into Phase 3 development of pemvidutide in metabolic ...

This data was produced from a multi-center study that enrolled 125 patients. The data demonstrates that VIVO was over 94% accurate, assisted physicians in determining workflow when used pre-procedure, ...